FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

THYROCARE

783.5
-17.85 (-2.23%)
Updated 03:28 23/09 IST

THYROCARE Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for THYROCARE
Disclaimer
0% Bullish
0% Bearish

THYROCARE Buy or Sell - Brokerage Reports

No. of reports in last year
4
No. of analysts
1
Average Consensus Forecast
506
Consensus Potential
-87.39%
See THYROCARE Share Price Targets >>

THYROCARE Ratings

Long term THYROCARE rating by FrontPage users
5/5 (3 Ratings)
Find answers to all your questions on live THYROCARE message board: Is THYROCARE buy or sell? Should I buy THYROCARE shares? Why are THYROCARE shares falling? Should I invest in THYROCARE stock?

  1. Home
  2. THYROCARE Forum

THYROCARE Share Price Discussion


Type
Buy
Instrument
THYROCARE
Entry Price
₹798
Price@Trade
₹799.4
Target Price
₹808
Stop Price
₹790
Valid Till
Sep 23, 2020 3:20 AM
Margin
₹159,600 approx for 200 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
BANKNIFTY 24SEP20 20800 PE
Entry Price
₹55
Price@Trade
₹57.6
Target Price
₹70
Stop Price
₹40
Valid Till
Sep 23, 2020 3:20 AM
Margin
₹137,500 approx for 2500 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
ASIANPAINT
Entry Price
₹1,942.05
Price@Trade
₹1,942.05
Target Price
₹5,000
Stop Price
₹500
Valid Till
Sep 23, 2021 3:20 AM
Margin
₹1,942.05 approx for 1 Qty
Status
Active
Like
Reply
O
Reputation: 2,474 • Yesterday 7:01 AM

Type
Sell
Instrument
EQUITAS
Entry Price
₹49.3
Price@Trade
₹49.4
Target Price
₹37.85
Stop Price
₹52.2
Valid Till
Oct 23, 2020 3:20 AM
Margin
₹49,300 approx for 1000 Qty
Status
Waiting for entry
Like
Reply
A
Reputation: -4,545 • Yesterday 7:01 AM

Type
Buy
Instrument
TECHM OCT20 810 CE
Entry Price
₹34.25
Price@Trade
₹34.25
Target Price
₹60
Stop Price
₹20
Valid Till
Oct 29, 2020 3:20 AM
Margin
₹411,000 approx for 12000 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
BHARTIARTL OCT20 FUT
Entry Price
₹440.45
Price@Trade
₹440.45
Target Price
₹500
Stop Price
₹400
Valid Till
Oct 29, 2020 3:20 AM
Margin
₹250,457.38 approx for 1851 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
SBIN
Entry Price
₹183.1
Price@Trade
₹183.1
Target Price
₹500
Stop Price
₹100
Valid Till
Sep 23, 2021 3:20 AM
Margin
₹3,662 approx for 20 Qty
Status
Active
Like
Reply
S
Reputation: 1,436 • Yesterday 7:01 AM

Type
Buy
Instrument
NIFTY 24SEP20 11200 CE
Entry Price
₹18
Price@Trade
₹24.75
Target Price
₹39
Stop Price
₹0
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹27,000 approx for 1500 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
BANKNIFTY 24SEP20 21600 CE
Entry Price
₹31  ₹38.8
Price@Trade
₹37.75
Target Price
₹75
Stop Price
₹0
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹970,000 approx for 25000 Qty
Status
Waiting for entry
Like
Reply (1)
See all replies

Update
Entry Price Modified
Price @ Update
₹38.8
Original Entry Price
₹31
New Entry Price
₹38.8

Type
Buy
Instrument
HEG
Entry Price
₹695
Price@Trade
₹701.5
Target Price
₹1,000
Stop Price
₹670
Valid Till
Oct 23, 2020 3:20 AM
Margin
₹69,500 approx for 100 Qty
Status
Waiting for entry
Like
Reply

Type
Buy
Instrument
BSE
Entry Price
₹533
Price@Trade
₹533
Target Price
₹1,000
Stop Price
₹100
Valid Till
Sep 23, 2021 3:20 AM
Margin
₹5,330 approx for 10 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
BANKNIFTY 24SEP20 21100 PE
Entry Price
₹165  151.0
Price@Trade
₹169.9
Target Price
₹350
Stop Price
₹60
Valid Till
Sep 23, 2020 3:20 AM
Margin
₹755,000 approx for 5000 Qty
Status
Waiting for entry
Like
Reply (3)
See all replies
MR GYANENDRA @mrgyanendra
Yesterday 7:00 AM

Update
Entry Price Modified
Price @ Update
₹163.95
Original Entry Price
₹165
New Entry Price
155.0
MR GYANENDRA @mrgyanendra
Yesterday 7:01 AM

Update
Entry Price Modified
Price @ Update
₹157.75
Original Entry Price
₹155
New Entry Price
150.0
MR GYANENDRA @mrgyanendra
Yesterday 7:01 AM

Update
Entry Price Modified
Price @ Update
₹156.8
Original Entry Price
₹150
New Entry Price
151.0
R
Reputation: -24,271 • Yesterday 6:59 AM

Type
Buy
Instrument
NIFTY 24SEP20 11100 PE
Entry Price
₹47.5
Price@Trade
₹47.5
Target Price
₹70
Stop Price
₹40
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹356,250 approx for 7500 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
INFY
Entry Price
₹1,016.85
Price@Trade
₹1,016.85
Target Price
₹2,000
Stop Price
₹500
Valid Till
Sep 23, 2021 3:20 AM
Margin
₹10,168.5 approx for 10 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
BANKNIFTY 24SEP20 21100 CE
Entry Price
₹182.95
Price@Trade
₹182.95
Target Price
₹300
Stop Price
₹147
Valid Till
Sep 24, 2020 3:20 AM
Margin
₹45,737.5 approx for 250 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
MARICO
Entry Price
₹345.35
Price@Trade
₹345.35
Target Price
₹1,000
Stop Price
₹100
Valid Till
Sep 23, 2021 3:20 AM
Margin
₹17,267.5 approx for 50 Qty
Status
Active
Like
Reply
Nifty Option Future in RELIANCE
New trade: Buy RELIANCE OCT20 2200 PE, CMP@78, ...
Like
Reply

Type
Buy
Instrument
BRITANNIA
Entry Price
₹3,574
Price@Trade
₹3,574
Target Price
₹10,000
Stop Price
₹500
Valid Till
Sep 23, 2021 3:20 AM
Margin
₹17,870 approx for 5 Qty
Status
Active
Like
Reply

Type
Buy
Instrument
CRUDEOIL 19OCT20 FUT
Entry Price
₹2,922
Price@Trade
₹2,921
Target Price
₹2,960
Stop Price
₹2,890
Valid Till
Sep 23, 2020 11:20 AM
Margin
₹295,650 approx for 100 Qty
Status
Active
Like
Reply (1)
See all replies
TrackerBot @trackerbot
Yesterday 6:58 AM

Update
Trade Entered
Entry Price
₹2,922
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • THYROCARE - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization2,801.04
    Enterprise Value2,791.99
    Price to Earnings33.64
    Price to Book Value6.14
    Return on Capital Employed0.33
    Return on Equity0.21
    Face Value10
    Dividend Yield0.02
  • THYROCARE - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    4-Aug-20Prabhudas LilladherSell307
    27-May-20Prabhudas LilladherSell307
    4-Feb-20Prabhudas LilladherBuy724
    8-Nov-19Prabhudas LilladherBuy686
    22-Aug-19Karvy Stock BrokingBuy526
    THYROCARE Brokerage Price Target
  • THYROCARE Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 23805.4815.35780.35786.55
    Sep 21804814.65745775.15
    Sep 18814.8819.95792.05805.9
    Sep 17782.4827782.4805.8
    Sep 16780.7795780.7788.4
  • THYROCARE Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹768.29
    30 Day Moving Average₹768.14
    50 Day Moving Average₹722.42
    100 Day Moving Average₹621.05
    200 Day Moving Average₹584.57
  • THYROCARE - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue332300.060.11
    Operating Profit137117.210.17
    Profit Before Tax148113.30.31
    Net Income9674.850.28
  • THYROCARE - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds4564540
    Total Liabilities3234-0.06
    Total Assets488488NA
  • THYROCARE - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity11289.270.25
    Cash from Investing Activity-48-39.650.21
    Cash from Financing Activity-65-48.50.34
    Net Cash Flow-11.11-1.9
  • THYROCARE - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.20.17
    Return on Equity0.210.18
    Return on Capital Employed0.330.27
  • THYROCARE - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.84
    3 Year CAGR Growth in Operating Profit0.83
    3 Year CAGR Growth in EBIDTA0.91
    3 Year CAGR Growth in Net Income0.95
    3 Yr CAGR Growth - Diluted EPS0.83
  • THYROCARE - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.47
    5 Year CAGR Growth in Operating Profit1.16
    5 Year CAGR Growth in EBIDTA0.98
    5 Year CAGR Growth in Net Income0.69
    3 Yr CAGR Growth - Diluted EPS-0.66
  • THYROCARE - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 8 6:13 AM
    Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Jul 21 4:58 AM
    Coronavirus in India | COVID-19 widespread but 18 crore Indians may already have immunity says Thyrocare's antibody tests
    Moneycontrol
    NewsBot
    Jul 21 12:41 PM
    Virus may be widespread, but not too lethal, indicate antibody tests at private labs
    The Economic Times
    NewsBot
    Jul 3 3:38 AM
    Coronavirus | Thyrocare Technologies launches 'COVID Antibody Tests'
    Moneycontrol
    NewsBot
    May 27 5:08 AM
    Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Apr 9 11:53 AM
    Free COVID-19 tests: Private labs cry foul, say need government support
    Moneycontrol
    NewsBot
    Mar 28 1:33 AM
    Practo ties up with Thyrocare to offer bookings of COVID-19 test on its platform
    Moneycontrol
    NewsBot
    Mar 18 4:58 AM
    Thyrocare Tech, Dr Lal PathLabs rise 9% as govt allow private lab to do coronavirus testing
    Moneycontrol
    NewsBot
    Feb 3 1:43 AM
    Stocks in the news: M&M, Maruti, Coal India, Tata Motors, Alkem Labs, Indian Bank
    Moneycontrol
    NewsBot
    Sep 23, 2019 1:58 AM
    Stocks in the news: Biocon, Petronet LNG, Hero Moto, Alkem Lab, PNB, Cipla, Torrent Pharma
    Moneycontrol
  • THYROCARE - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020